India Commercial Operations

Mylan launched its commercial operations in India in August 2012 with a broad, innovative portfolio of antiretrovirals used to treat HIV/AIDS, including heat-stable combinations and pediatric formulations. Since then, Mylan has added four other segments – Critical Care, Onco Care, Women’s Care, and, most recently, Hepato Care.

To complement our product offerings, Mylan India offers several educational programs to empower healthcare professionals to treat their patients more effectively and help patients better manage their disease.

Today, Mylan India’s sales force has grown to more than 400 professionals who are committed to expanding access to high quality, affordable medicine.

Critical Care

Mylan India’s Critical Care segment caters to the needs of seriously ill patients in intensive care units, with antifungal, antibacterial and anticoagulant therapies.

Hepato Care

Hepato Care

Our Hepato Care segment helps address a major public health problem in India by expanding access to life-saving hepatitis C treatments.  

HIV Care

Through our HIV Care segment, Mylan India offers a comprehensive portfolio of high quality, affordable antiretrovirals for the treatment of HIV/AIDS.

Onco Care

Our Onco Care division offers a portfolio of cancer-related cytotoxic and targeted therapy products for common types of cancers, such as breast, lung and colorectal.

Women's Care

Mylan India’s Women’s Care business focuses on infertility treatments, pre- and post-natal care and post menopause care.

Reaching Patients in India

Mylan launched its domestic operations in India in August 2012 with a broad, innovative portfolio of antiretrovirals used to treat HIV/AIDS.

  • Questions?

    Get more information on our products, services and Mylan Global Center locations.
    Contact Us
  • Business Opportunities

    Do you have an opportunity or a collaboration idea?
    Partner with us